These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 87625)

  • 1. The atypical-measles syndrome.
    Lancet; 1979 May; 1(8123):962-3. PubMed ID: 87625
    [No Abstract]   [Full Text] [Related]  

  • 2. Exaggerated natural measles following attenuated virus immunization.
    St Geme JW; George BL; Bush BM
    Pediatrics; 1976 Jan; 57(1):148-9. PubMed ID: 1246490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency control of live, attenuated vaccines against measles used in children vaccinations in the State of São Paulo, Brazil [1976-1980].
    Pral MM; Woe Fang FL; de Rizzo E
    Rev Inst Med Trop Sao Paulo; 1982; 24(1):1-5. PubMed ID: 7123066
    [No Abstract]   [Full Text] [Related]  

  • 4. [Atypical measles following immunization with inactivated measles vaccine (split vaccine)].
    Hagge W; Enders-Ruckle G; von Brenndorff AI
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):504-6. PubMed ID: 4408628
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of measles vaccines in Japan.
    Ueda S
    Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistence of immunity to attenuated measles live vaccine. V. Persistence of immunity after primary immunization with 4 strains of live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1983 Aug; 63(8):490-2. PubMed ID: 6418341
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical measles following immunization with killed measles vaccine.
    McLean DM; Kettyls GD; Hingston J; Moore PS; Paris RP; Rigg JM
    Can Med Assoc J; 1970 Oct; 103(7):743-4. PubMed ID: 5506110
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 9. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.
    Hirose M; Hidaka Y; Miyazaki C; Ueda K; Yoshikawa H
    Scand J Infect Dis; 1997; 29(2):187-90. PubMed ID: 9181657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 11. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current problems in measles. II. Measles vaccines--recent progress].
    Ciufecu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(3):259-78. PubMed ID: 6438773
    [No Abstract]   [Full Text] [Related]  

  • 13. [The cell-mediated response after measles vaccination].
    Pala S; Crimaldi G; Consolini R; Macchia P
    Pediatr Med Chir; 1998; 20(3):213-6. PubMed ID: 9744016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles.
    Polack FP; Hoffman SJ; Crujeiras G; Griffin DE
    Nat Med; 2003 Sep; 9(9):1209-13. PubMed ID: 12925847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical measles with hepatic involvement].
    Riaño Galán I; Alonso Villa MJ; Cimadevilla Suárez R; Martínez Gutiérrez A
    An Esp Pediatr; 1992 May; 36(5):399-400. PubMed ID: 1616204
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical reactogenicity and immunogenicity of five live measles vaccine strains.
    Chin Med J (Engl); 1981 Apr; 94(4):201-6. PubMed ID: 6790234
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome.
    Ahlgren C; Odén A; Haghighi S; Andersen O; Bergström T; Lycke J
    J Neuroimmunol; 2011 Jun; 235(1-2):98-103. PubMed ID: 21550125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Persistence of immunity to attenuated measles live vaccine. VI. Observation on the results of revaccination with different vaccines via varied routes].
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):541-5. PubMed ID: 6418355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.